Patent holdings for IPC class C07D 311/58

Total number of patents in this class: 425

10-year publication summary

34
30
31
28
43
43
29
27
20
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Lupin Limited
446
11
Mochida Pharmaceutical Co., Ltd.
345
10
Aardvark Therapeutics Inc.
46
10
Bristol-myers Squibb Company
4886
9
Menarini International Operations Luxembourg S.A.
94
8
BASF SE
20367
7
Artax Biopharma Inc.
17
7
F.I.S. Fabbrica Italiana Sintetici S.p.A.
126
7
Queen's University at Kingston
534
7
AbbVie Deutschland GmbH & Co. KG
261
6
Askat Inc.
56
6
Euclises Pharmaceuticals, Inc.
14
6
Neoculi Pty Ltd
18
6
Abbvie Inc.
1781
5
Gilead Sciences, Inc.
1949
5
Biosplice Therapeutics, Inc.
162
5
DSM IP Assets B.V.
5817
4
Canopy Growth Corporation
261
4
CHDI Foundation, Inc.
108
4
The University of British Columbia
1464
4
Other owners 294